Frequency Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Korro Bio

15/05/2021 08:47

* Frequency Therapeutics Inc  FREQ.OQ  reported a quarterly
adjusted loss of 60 cents​​ per share for the quarter ended
in March. The mean expectation of four analysts for the quarter
was for a loss of 28 cents per share.
* Revenue fell 36% to $4.65 million from a year ago;  analysts
expected $8.13 million. 
* Frequency Therapeutics Inc's reported EPS for the quarter was
a loss of 60 cents​.
* The mean earnings estimate of analysts had fallen by
about 383% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Frequency Therapeutics Inc shares had fallen by 15.3% this
quarter and lost 77.2% so far this year.
* The company reported a quarterly loss of $20.38 million.
* Wall Street's median 12-month price target for Frequency
Therapeutics Inc is $15.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated May 15 at 07:47 a.m. GMT.
​All figures in US dollars